Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Hormone Refractory”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Ended earlyNCT03861403
What this trial is testing

A Dose Escalation and Expansion Study of TRX518 in Combination With Cyclophosphamide Plus Avelumab in Advanced Solid Tumors

Who this might be right for
Solid TumorsAdvanced Triple Negative Breast CancerAdvanced Hormone Receptor Positive/Endocrine Refractory Breast Cancer+2 more
Leap Therapeutics, Inc. 10
Testing effectiveness (Phase 2)Ended earlyNCT00132756
What this trial is testing

Liposomal Doxorubicin and Estramustine Phosphate: Study in Taxane Resistant, Hormone Refractory Advanced Prostate Cancer

Who this might be right for
Prostate Cancer
Morton Plant Mease Health Care 30
Testing effectiveness (Phase 2)Study completedNCT00446836
What this trial is testing

Efficacy and Safety Study of Xyotax to Treat Prostate Cancer

Who this might be right for
Prostatic Neoplasms
The Methodist Hospital Research Institute 29
Testing effectiveness (Phase 2)Study completedNCT01215799
What this trial is testing

Study of Bafetinib (INNO-406) as Treatment for Patients With Hormone-Refractory Prostate Cancer

Who this might be right for
Hormone Refractory Prostate Cancer
CytRx 23
Testing effectiveness (Phase 2)Study completedNCT00004014
What this trial is testing

Liposomal Doxorubicin in Treating Patients With Prostate Cancer

Who this might be right for
Prostate Cancer
Case Comprehensive Cancer Center 10
Testing effectiveness (Phase 2)Ended earlyNCT02215161
What this trial is testing

Selinexor in Treating Patients With Abiraterone Acetate and/or Enzalutamide Refractory Metastatic Castration-Resistant Prostate Cancer

Who this might be right for
Castration Levels of TestosteroneHormone-Resistant Prostate CancerMetastatic Prostate Carcinoma in the Soft Tissue+3 more
University of California, San Francisco 14
Testing effectiveness (Phase 2)Ended earlyNCT01450683
What this trial is testing

Study of Itraconazole in Castrate-resistant Prostate Cancer (CRPC) Post-chemotherapy

Who this might be right for
Prostate CancerProstatic NeoplasmsCastrate-resistant Prostate Cancer (CRPC)+3 more
Stanford University 4
Testing effectiveness (Phase 2)Ended earlyNCT00176293
What this trial is testing

Randomized Phase II Trial of Doxil With or Without Dexamethasone for Metastatic Hormone Refractory Prostate Cancer

Who this might be right for
Prostate Cancer
University of Kentucky 2
Testing effectiveness (Phase 2)Study completedNCT01171729
What this trial is testing

Autologous Dendritic Cell Therapy for Hormone-Refractory Metastatic Prostate Cancer

Who this might be right for
Prostatic Cancer
Samsung Medical Center 12
Large-scale testing (Phase 3)Study completedNCT00004001
What this trial is testing

S9916, Combination Therapy in Treating Patients With Advanced Prostate Cancer That Has Not Responded to Hormone Therapy

Who this might be right for
Prostate Cancer
SWOG Cancer Research Network 770
Testing effectiveness (Phase 2)Ended earlyNCT00753220
What this trial is testing

Safety Study of Autologous Dendritic Cells Injected Into the Prostate After Cryoablation for Advanced Prostate Cancer

Who this might be right for
Prostate Cancer
Bostwick Laboratories 7
Large-scale testing (Phase 3)Ended earlyNCT00450970
What this trial is testing

Expanded Access Study of Satraplatin Plus Prednisone in Patients With Hormone Refractory Prostate Cancer (HRPC)

Who this might be right for
Prostate Cancer
Agennix 344
Large-scale testing (Phase 3)Study completedNCT00134056
What this trial is testing

S0421, Docetaxel and Prednisone With or Without Atrasentan in Treating Patients With Stage IV Prostate Cancer and Bone Metastases That Did Not Respond to Previous Hormone Therapy

Who this might be right for
Metastatic CancerProstate Cancer
SWOG Cancer Research Network 1,038
Testing effectiveness (Phase 2)Study completedNCT00082134
What this trial is testing

Study of ILX651 in Patients With Hormone-Refractory Prostate Cancer Previously Treated With Docetaxel

Who this might be right for
Hormone-refractory Prostate Cancer
Genzyme, a Sanofi Company 40
Testing effectiveness (Phase 2)Study completedNCT00118092
What this trial is testing

17-AAG in Treating Patients With Metastatic Prostate Cancer That Did Not Respond to Previous Hormone Therapy

Who this might be right for
Adenocarcinoma of the ProstateRecurrent Prostate CancerStage IV Prostate Cancer
National Cancer Institute (NCI) 17
Post-approval studies (Phase 4)Study completedNCT02074137
What this trial is testing

Evaluation of Safety of Cabazitaxel (Jevtana) in Patients With Metastatic Hormone Refractory Prostate Cancer

Who this might be right for
Prostate Cancer Metastatic
Sanofi 10
Early research (Phase 1)Study completedNCT00401765
What this trial is testing

CNTO 328 in Patients With Metastatic Hormone-Refractory Prostate Cancer

Who this might be right for
Prostatic Neoplasms
Centocor, Inc. 40
Testing effectiveness (Phase 2)Study completedNCT00049257
What this trial is testing

Paclitaxel and Carboplatin in Treating Patients With Metastatic Prostate Cancer That Has Not Responded to Hormone Therapy

Who this might be right for
Prostate Cancer
Jonsson Comprehensive Cancer Center 58
Large-scale testing (Phase 3)Study completedNCT00255606
What this trial is testing

Docetaxel and Prednisone in Treating Patients With Hormone-Refractory Metastatic Prostate Cancer

Who this might be right for
Prostate Cancer
Tampere University 360
Large-scale testing (Phase 3)Study completedNCT00060398
What this trial is testing

Epoetin Alfa With or Without Dexamethasone in Treating Fatigue and Anemia in Patients With Hormone-Refractory Prostate Cancer

Who this might be right for
AnemiaFatigueProstate Cancer
Eastern Cooperative Oncology Group 282
Next Page